GLAXOSMITHKLINE PLC (GSK)
Company Overview
Glaxo has 3 core businesses - Pharmaceuticals, Vaccines and Consumer Healthcare. The company has made significant progress in expanding its presence in emerging markets by acquiring product portfolios from companies like Bristol-Myers and UCB. In August 2019, Glaxo and Pfizer merged their consumer healthcare unit into a new JV. Glaxo owns a controlling stake in the JV. Glaxo plans to split itself into two standalone companies. The new Glaxo will be a biopharma company. Glaxo intends to separate its Consumer Healthcare segment into a standalone company in 2022. The independent Consumer Healthcare company will be named Haleon. In 2015, Glaxo divested two quadrivalent meningitis ACWY vaccines ' Nimenrix and Mencevax ' to Pfizer, a portfolio of OTC brands to Perrigo, and all its remaining rights to Arzerra for auto-immune indications including multiple sclerosis to Novartis. In January 2019, Glaxo acquired Tesaro, an oncology focused biotech company, which added the PARP inhibitor Zejula to its portfolio.
Contact Details
- Address
- 980 GREAT WEST ROAD
- City
- BRENTFORD
- State
- X0
- Country
- GBR
- Zip Code
- TW8 9GS
- Phone Number
- 44-20-8047-5000
- Website
- -
Financial Highlights
-
Day Range
The price range a stock has traded at during the most recent trading period.
-
--
-
5 Day Range
The price range a stock has traded at during the previous 5 days.
-
--
-
3 Month Range
The price range a stock has traded at during the previous 3 months.
-
--
-
52 Week Range
The price range a stock has traded at during the previous 52 weeks.
-
--
-
Previous Close
The closing price of a stock from the previous day.
-
-
Open
The price of the stock at the start of today’s market opening.
-
-
Bid
The amount of money a trader is willing to pay per share for a given stock.
-
x-
-
Ask
The amount of money a seller wants per share of a given stock.
-
x-
-
Volume
The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.
-
-
Avg. Volume
The average number of shares traded in a given day.
-
-
Dividend Yield
A company's annual dividend expressed as a percentage of its current stock price.
-
-
Recent Dividend
The value a shareholder receives from a company they are invested in for holding their shares.
-
-
Beta
A measurement of the stock’s volatility in comparison to the market as a whole.
-
Shareholding
-
Shares Outstanding
Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.
-
-
Insider Shareholders
The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.
-
-
Institutional Shareholders
The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.
-
-
Market Cap
The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.
-
-
Revenue TTM
The amount of money a company has made for the trailing twelve-month period.
-
-
Net Income TTM
A measurement of how much profit they are retaining for the trailing twelve-month period.
-
-
P/E Ratio
The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.
-
-
EPS TTM
Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.
-
-
1 Year Return
A measurement of how much the stock has increased or decreased in the last year.
-
There is no stock data currently available for this time period, please select another option.
Please wait, gathering market data...
Latest News
View MoreUS challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
View More![](https://files.valuethemarkets.com/containers/assets/images/2024/04/7762e64796be412dbc5d22977cf9aff9_main_drug_patents_09215.jpg/1c3f0e379b0a09786123a3d9cac2f800.jpg)
Latest Analysis
View MoreIn the headlines Nov 1: PBR, WYNN, MSFT, ATVI, GSK
View More![](https://files.valuethemarkets.com/containers/assets/pbr-stock-min.jpeg/99a3a75385ddaf6dc4cea7c88434216b.jpeg)